Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
How would you (non-surgically) approach and treat two synchronous distinct oropharynx T1-T2N0 primaries with definitive RT?
Would you add concurrent systemic therapy with radiation due to concern for field cancerization?
Answer from: Radiation Oncologist at Academic Institution
RT to oropharynx and bilateral neck. I can’t imagine that both are lateralized to one side. If so, one cancer. No chemo.
Sign In
or
Register
to read more
Answer from: Radiation Oncologist at Community Practice
No.
Sign In
or
Register
to read more
9966
9969
Related Questions
How do you approach cisplatin dosing for locally advanced head and neck SCC in HPV-positive and HPV-negative patients?
How would you approach post-op radiation recommendations in patients who had neoadjuvant chemoimmunotherapy for HPV mediated OPSCC s/p TORS who have a complete pathologic response (pCR)?
What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?
What GTV to CTV expansion do you utilize for NPC?
How do you counsel patients regarding alcohol consumption following treatment of head and neck cancer?
For an upper lip (near midline) Merkel cell carcinoma s/p wide local excision with negative SLNB and no adjuvant RT, with the recurrence to one side of the neck a year later, should the contralateral neck be included in the radiation field?
How are you integrating the findings from KEYNOTE-689 into daily practice?
How would you manage the side effects/toxicities (e.g., pain, swelling, erythema) of adjuvant EBRT to the ear for cutaneous SCC?
What is your recommendation for patients who are on weight loss medications like GLP-1-based therapies while receiving chemoradiation for head and neck cancer?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?